Arkansas State and Public School Employees Preferred Drug List (PDL) - Effective 01/01/2014
This PDL is a list of the most commonly prescribed drugs. It is not all-inclusive and is not a guarantee of coverage. Plan Benefit Design is the final determinate of coverage. For drugs not listed, please call the pharmacy program number listed on the back of your ARBenefits ID card for benefit coverage information.
PLEASE NOTE: Use of generic drugs can save both you and your health plan money. Generics that are new to the market will require a copyment equal to its branded product. These are indicated in the PDL with *(NG) and are shown in bold type. These new generics will not have the standard Tier 1 copayment that older generic products have. In addition, brand-name medications that are available in the generic form will require a generic drug copayment PLUS the difference in the plan's cost between the generic and equivalent brand-name drug. Specialty drugsmay require prior authorization (PA) by EBRx (1-866-564-8258) to ensure appropriate usage. These medications are indicated in the PDL located under Tier 4. Compounded medicationswill require prior authorization (PA). Your physician may request a PA by contacting EBRx at (1-866-564- 8258). Key: Certain drugs (*) may be subject to Day Supply (DS), Quantity Limits (QL), Prior Authorization (PA), Step Therapy (ST), Contingent Therapy (CT), New Generics (NG) or Reference Pricing (RP) requirements according to Benefit Design. Items indicated as *(RP) require special copayment pricing and do not apply to the standard tier copayments. This PDL is subject to change at any time. ANTI-INFECTIVES
cefaclor, cefadroxil, cephalexin, Cedax, Spectracef,
Kaletra, Lexiva, Sustiva, Combivir, Epivir
Aptivus, Atripla, Crixivan, Emtriva, Epzicom, Invirase, Isentress*(PA), Prezista, Prezista soln*(PA), Rescriptor, Reyataz, Trizivir, Truvada*(PA), Selzentry, Stribild tablet*(QL)*(PA) Baraclude, Pegasys*(PA), Peg- Intron*(PA), Victrelis*(PA) CARDIOVASCULAR *(RP) Reference Priced
Altoprev, Crestor 5mg, Lescol, Lescol XL, Lipitor, Mevacor, Pravachol,
Antihyperlipidemic-HMG (Statins): Plan pays $0.30 per unit. Member is responsible for remaining cost.
Other Antihyperlipidemic cholestyramine resin, colestipol, Niaspan, niacin extended release tablet*(NG), Welchol tablet
ACE Inhibitors and ACE amlodipine/benazepril, captopril,
Antagonist (ARB)/Direct irbesartan/HCTZ, irbesartan, Renin Inhibitors (DRI)
*(RP) Reference Priced
Amturnide, Atacand, candesartan*(NG), Atacand HCT, candesartan
Antagonist (ARB)/Direct Angiotensin Receptor
cilexetil/HCTZ, Avalide, Avapro, Azor, Benicar, Benicar HCT, Cozaar,
Blockers (ARB): Plan pays
Diovan, Diovan HCT, valsartan/HCTZ, Edarbi, Edarbyclor, Exforge, Exforge
$0.81 per unit. Member is
HCT, Hyzaar, Micardis, telmisartan*(NG), Micardis HCT, Tekturna, responsible for remaining
Tekturna HCT, Teveten, Teveten HCT, Twynsta,
telmisartan/amlodipine*(NG) *(RP) Reference Priced
Caduet---all other strengths (brand and generic). No prior authorization Antihypertensive--Other: (PA) required. Plan pays $0.30 per unit. Member is responsible for remaining cost.
Lopressor, Lopressor HCT, Tenoretic, Tenormin, Toprol XL
Cardizem, LA, SR, CD, Norvasc, Sular, Tiazac, Verelan PM
CENTRAL NERVOUS SYSTEM
CD*(QL), ER*(QL), Provigil* (PA), Ritalin Tablet, LA*(QL), SR, Vyvanse*(QL)
*(RP) Long Acting
Long Acting Amphetamines are reference priced for members 26 years of Amphetamines: Plan pays
age or older; *Quantity Limits will still apply to reference priced long $2.50 per unit. Member is responsible for remaining cost.
Adderall XR*(QL), amphetamine salts*(QL) extended release, Dexedrine*(QL), dextroamphetamine*(QL) extended release, Vyvanse*(QL)
Aricept, donepezil*(NG), Aricept ODT, Exelon, Namenda*(PA), Namenda XR*(PA), Razadyne, Razadyne ER
Percocet*(QL), Percodan, Tylenol w Codeine*(QL)
Lamictal CD, Neurontin, Potiga*(PA), Phenytek, Tegretol, Topamax, Trileptal, Zonegran
*(RP) Reference Priced
Lyrica (Note: The generic drug gabapentin will remain at a Tier 1 copay.) Anticonvulsants: Plan pays $0.35 per unit. Member is responsible for the remaining cost. *(RP) Serotonin
Cymbalta, duloxetine, Effexor XR, venlafaxine extended release tablets norepinephrine reuptake inhibitors (SNRIs): Plan pays
Antidepressants (SNRIs) $0.75 per unit. Member is responsible for remaining cost.
sertraline, fluoxetine, paroxetine, citalopram, fluvoxamine
*(RP) Selective serotonin
Lexapro, escitalopram, Luvox CR, fluvoxamine ER, Paxil ER, paroxetine
Antidepressants (SSRIs) reuptake inhibitors (SSRIs): ER, Pexeva Plan pays $0.30 per unit. Member is responsible for remaining cost.
Requip, Requip XL, Sinemet, Sinemet CR, Stalevo
Symbyax, Risperdal-M, Zyprexa, Zyprexa-Zydis ODT
Imitrex*(QL), Maxalt*(QL), Maxalt MLT*(QL), Zolmitriptan*(NG)*(QL), Zomig*(QL), Zomig - ZMT*(QL)
Multiple Sclerosis Drugs no generics available at this
Aubagio tablet*(PA)*(QL), Avonex, Betaseron, Copaxone, Extavia, Gilenya, Rebif, Tecfidera*(PA)*(QL) *(RP) Reference Priced
Ambiem, Ambien CR, Lunesta, Rozerem, Sonata, zaleplon
Sedatives/Hypnotics: Plan pays $0.15 per unit. Member is responsible for remaining cost.
Lioresal, Parafon Forte, Skelaxin, Zanaflex, Zanaflex Caps
ENDOCRINE
glipizide, glyburide, nateglinide, repaglinide*(NG)
Janumet*(PA), Kazano*(PA), Kombiglyze XR*(PA), Nesina*(PA), Onglyza*(PA), Oseni*(PA), Precose, Tradjenta*(PA)
Diabetic testing strips will now require a copay. Several Tier 1 options are available. Covered test strips are listed below. Other diabetic testing supplies (lancets and needles) will be provided at a $0 copay to members actively enrolled in the Diabetes Management Program .
Contour, Bayer Breeze, Accu-Chek Aviva, Accu-Chek Compact, Accu-Chek Smartview, Accu-Chek Comfort Curve, Freestyle, Freestyle Lite
GASTROINTESTINAL/URINARY strengths), Pertyze, Ultrase, Viokace, Zenpep
20mg, omeprazole 40mg, pantoprazole 20 & 40 mg
*(RP) Reference Priced
Aciphex, Dexilant, lansoprazole, Nexium, omeprazole/sodium bicarb
Proton Pump Inhibitors: Plan capsule,Prevacid, Prevacid 24hr OTC, Prilosec, Prilosec OTC, omeprazole pays $0.30 per unit. Member OTC, Protonix, Zegerid capsule is responsible for remaining cost.
Bowel Preparation Drugs Gavilyte-C/G, PEG
oxybutynin (extended release and immediate release)
*(RP) Reference Priced
Detrol, tolterodine, Detrol LA, tolterodine (extended release),Ditropan,
Overactive Bladder Agents:
Ditropan XL, Enablex, Oxytrol Patch, Sanctura, trospium, Sanctura XR,
Plan pays $2.12 per unit. Member is responsible for remaining cost. MEN'S HEALTH RESPIRATORY *(RP) Reference Priced Nasal Beconase, Beconase AQ, Flonase, Nasonex, mometasone, Nasacort AQ, Steroids: Plan pays up to $26.00 for a one month supply. Member is responsible for remaining cost.
Advair*(ST), Combivent, Atrovent Inhaler,
Xolair*(PA)
ipratropium, theophylline 200mg Prelone, Spiriva,
Azopt, Betimol, Lumigan Timoptic, Trusopt,
Bepreve, Crolom, Elestat, Emadine, Lastacaft, Optivar, Patanol, Zaditor
lidocaine*(NG), Locoid Gel, Halonate Kit, Lipocream, Pramosone, Lotrisone lotion, Synalar, Protopic
Duac Gel, Noritate, Retin-Benzaclin, Benzamycin,
A 0.05% topical solution, Cleocin T, Klaron, Retin-
phosphate-benzoyl peroxide gel, Amnesteem, Claravis, Sotret, sulfacetamide sodium 10% topical solution, tretinoin
WOMEN'S HEALTH
FemHRT 0.5mg/2.5mg, Activella, Climara Pro,
Contraceptives: Plan will pay 100% for all COVERED GENERICS . COVERED BRANDS with no generic available will be covered by the plan under Tier 3 (limited to oral forms). *** Brand/Generic difference/penalty pricing will apply if member chooses a COVERED BRAND where a generic is available.*** Examples of COVERED GENERICS paid at 100%:
Amethia, Aviane, Azurette, Camrese, Camrese Lo, Cryselle, Daysee, Elinest, Emoquette, Enpresse, Gianvi, Gildess, Introvale, Jolessa, Kariva, Lessina, Levora, LoSeasonique, Loryna, Low-Ogestrel, Lovonest, Lutera, Marlissa, Microgestin, Mircette,
Mono-Linyah, MonoNessa, Myzilra, Necon, Nortrel, Ocella, Ogestrel, Orsythia, Ortho-Cyclen,Ortho-Novum, Portia, Previfem, Quasense, Reclipsen, Seasonique, Sprintec, Sronyx, Syeda, Tilia, Trinessa, Tri-Linyah, Tri-Sprintec, Trivora, Wymzya, Vestura, Viorele,Yasmin,Yaz Zarah, Zenchent
Examples of COVERED BRANDS paid at 100%:
Alora, Cenestin, Estrace Climara, Enjuvia, Estrace
Menest, Premarin, Prometrium, Vagifem, Vivelle-Dot
Atelvia, Boniva, Didronel, Forteo*(PA) Prolia*(PA)
Concept DHA, Concept Complete-RF Prenatal,
OB, Folcal DHA, Folcaps Folivane-OB, HemeNatal
PNV, L-Methylfolate PNV O-Cal Prenatal, Venatal-
DHA, Tamdem DHA, Virt-FA, Venate, Vol-Nate,
RX 1, Ultimatecare One, Vinate PN, Zatean-PN
MISCELLANEOUS
Anzemet*(QL), acitretin*(NG), Amevive*(PA), Enbrel*(PA), Stelara*(PA) Humatrope*(PA), Genotropin*(PA), Norditropin*(PA), Nutropin/AQ*(PA), Saizen*(PA), Serostim*(PA), Tev- Tropin*(PA)
Myfortic, Prograf capsule, Nulojix*(PA), Rapamune, Simulect
methotrexate*(PA), leflunomide Trexall*(PA)
Actemra*(PA), Enbrel*(PA), Humira*(PA), Kineret*(PA), Orencia*(PA), Remicade *(PA), Simponi*(PA), Xeljanz*(PA) Specialty Drug List This Specialty Drug List includes medications that are classified as Tier 4 drugs (by plan coverage) and most will require pre-authorization by EBRx (1-866-564-8258) when obtained from the pharmacy or administered in the physician's office. The coverage requirements for prescribing or administering these medications can be found on the ARBenefits website at www.ARBenefits.org ACROMEGALY GROWTH HORMONE & RELATED DISORDERS ALPHA-1 ANTITRYPSIN DEFICIENCY Aralast IGF-1 Deficiency BOTULINUM TOXINS HEMATOPOIETICS CROHN’S DISEASE HEMOPHILIA & RELATED BLEEDING DISORDERS CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES CYSTIC FIBROSIS ENZYME DEFICIENCY OR LYSOSOMAL STORAGE DISEASE Aldurazyme HEPATITIS B MACULAR DEGENERATION HEPATITIS C MULTIPLE SCLEROSIS ONCOLOGY – ORAL ONCOLOGY - SUPPORTIVE CARE OSTEOARTHRITIS Euflexxa HORMONAL THERAPIES OSTEOPOROSIS IMMUNE DEFICIENCY PLAQUE PSORIASIS IMMUNE THROMBOCYTO-PENIC PURPURA IRON OVERLOAD PSORIATIC ARTHRITIS PULMONARY ARTERIAL HYPERTENSION TRANSPLANT RESPIRATORY SYNCYTIAL VIRUS OTHER THERAPIES RHEUMATOID ARTHRITIS
Deliberazione 21 maggio 1998 Determinazione delle aliquote definitive per gli anni 1991, 1992, 1993, 1994 e 1995, ai fini della corresponsione da parte della cassa conguaglio per il settore elettrico dell’integrazione tariffaria spettante alle imprese elettriche minori non trasferite all’Enel (Deliberazione n. 48/98) • Premesso che in conformità dell’articolo 3, comma 1,